Literature DB >> 31260083

Transient hypogammaglobulinaemia of infancy: many patients recover in adolescence and adulthood.

R Ameratunga1,2, Y Ahn1, R Steele1, S-T Woon1.   

Abstract

Transient hypogammaglobulinaemia of infancy (THI) is a relatively rare disorder where there is an exaggeration of the physiological nadir of immunoglobulin (Ig)G between loss of transplacentally acquired maternal IgG and production by the infant. Patients may be vulnerable to infections during the period of hypogammaglobulinaemia. The precise time to recovery in all infants is currently unknown. We sought to determine the clinical features and time-course of recovery for patients with THI. We reviewed our experience with THI over the last three decades in order to describe clinical and laboratory features, as well as the time-course of recovery. Forty-seven patients were identified with THI. Only thirty-seven per cent remitted by 4 years of age, while some patients did not recover until the third or fourth decade. In keeping with previous studies, the majority (25 of 47) presented with recurrent infections, nine had a family history of immunodeficiency and 13 had adverse reactions to food as their dominant clinical manifestation. Chronic tonsillitis developed in 10 patients and symptoms improved following surgery. The group with food allergies recovered sooner than those presenting with infections or with a family history immunodeficiency. Eight patients failed to respond to at least one routine childhood vaccine. Two have IgA deficiency and four individuals recovering in adolescence and adulthood continue to have borderline/low IgG levels. None have progressed to common variable immunodeficiency disorders (CVID). THI is a misnomer, as the majority do not recover in infancy. Recovery from THI can extend into adulthood. THI must be considered in the differential diagnosis of adolescents or young adults presenting with primary hypogammaglobulinemia.
© 2019 British Society for Immunology.

Entities:  

Keywords:  common variable immunodeficiency disorders; hypogammaglobulinaemia; hypogammaglobulinaemia of uncertain significance; immunodeficiency; transient hypogammabulinemia of infancy

Year:  2019        PMID: 31260083      PMCID: PMC6797871          DOI: 10.1111/cei.13345

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Agammaglobulinemia, congenital, acquired and transient forms.

Authors:  D GITLIN; C A JANEWAY
Journal:  Prog Hematol       Date:  1956

2.  Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.

Authors:  Manfred Fliegauf; Vanessa L Bryant; Natalie Frede; Charlotte Slade; See-Tarn Woon; Klaus Lehnert; Sandra Winzer; Alla Bulashevska; Thomas Scerri; Euphemia Leung; Anthony Jordan; Baerbel Keller; Esther de Vries; Hongzhi Cao; Fang Yang; Alejandro A Schäffer; Klaus Warnatz; Peter Browett; Jo Douglass; Rohan V Ameratunga; Jos W M van der Meer; Bodo Grimbacher
Journal:  Am J Hum Genet       Date:  2015-08-13       Impact factor: 11.025

3.  New diagnostic criteria for CVID.

Authors:  Rohan Ameratunga; See-Tarn Woon; David Gillis; Wikke Koopmans; Richard Steele
Journal:  Expert Rev Clin Immunol       Date:  2014-02       Impact factor: 4.473

Review 4.  Review: Diagnosing Common Variable Immunodeficiency Disorder in the Era of Genome Sequencing.

Authors:  Rohan Ameratunga; Klaus Lehnert; See-Tarn Woon; David Gillis; Vanessa L Bryant; Charlotte A Slade; Richard Steele
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 5.  The four most common pediatric immunodeficiencies.

Authors:  Richard E Stiehm
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

6.  Variability of memory B cell markers in a cohort of common variable immune deficiency patients over 6 months.

Authors:  W Koopmans; S-T Woon; I S L Zeng; A Jordan; S Brothers; P Browett; R Ameratunga
Journal:  Scand J Immunol       Date:  2013-06       Impact factor: 3.487

7.  Transient hypogammaglobulinemia of infancy and early childhood: outcome of 30 cases.

Authors:  Figen Doğu; Aydan Ikincioğullari; Emel Babacan
Journal:  Turk J Pediatr       Date:  2004 Apr-Jun       Impact factor: 0.552

8.  The outcome of patients with unclassified hypogammaglobulinemia in early childhood.

Authors:  Necil Kutukculer; Nesrin Gulez
Journal:  Pediatr Allergy Immunol       Date:  2009-01-31       Impact factor: 6.377

9.  Symptomatic hypogammaglobulinemia in infancy and childhood - clinical outcome and in vitro immune responses.

Authors:  Mona Iancovici Kidon; Zeev T Handzel; Rivka Schwartz; Irit Altboum; Michael Stein; Israel Zan-Bar
Journal:  BMC Fam Pract       Date:  2004-10-21       Impact factor: 2.497

10.  Transient hypogammaglobulinemia and severe atopic dermatitis: Open-label treatment with immunoglobulin in a case series.

Authors:  Moira E Breslin; Joanna H Lin; Robert Roberts; Kellie J Lim; E Richard Stiehm
Journal:  Allergy Rhinol (Providence)       Date:  2016-07-27
View more
  5 in total

1.  Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand Common Variable Immunodeficiency Disorders cohort study.

Authors:  R Ameratunga; A Jordan; A Cavadino; S Ameratunga; T Hills; R Steele; M Hurst; B McGettigan; I Chua; M Brewerton; N Kennedy; W Koopmans; Y Ahn; R Barker; C Allan; P Storey; C Slade; A Baker; L Huang; S-T Woon
Journal:  Clin Exp Immunol       Date:  2021-04-12       Impact factor: 5.732

2.  Transient hypogammaglobulinemia of infancy may be associated with reduced switched memory B cells and del (16) (p11.2p12).

Authors:  Tsuyoshi Ito; Shotaro Iwamoto; Masahiro Hirayama; Yasuharu Yamada; Eiichi Azuma
Journal:  Clin Case Rep       Date:  2021-06-22

3.  The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).

Authors:  Rohan Ameratunga; Yeri Ahn; Richard Steele; See-Tarn Woon
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

4.  All Patients With Common Variable Immunodeficiency Disorders (CVID) Should Be Routinely Offered Diagnostic Genetic Testing.

Authors:  Rohan Ameratunga; Klaus Lehnert; See-Tarn Woon
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

5.  Are All Primary Immunodeficiency Disorders Inborn Errors of Immunity?

Authors:  Rohan Ameratunga; Hilary Longhurst; Klaus Lehnert; Richard Steele; Emily S J Edwards; See-Tarn Woon
Journal:  Front Immunol       Date:  2021-07-21       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.